SBIR-STTR Award

Noninvasive Assay of Total Hemoglobin by Kromoscopy
Award last edited on: 1/8/09

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$643,608
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Myron J Block

Company Information

Optix Inc

113 North Beach Road Box 685
Jupiter, FL 33455
   N/A
   N/A
   N/A
Location: Single
Congr. District: 18
County: Martin

Phase I

Contract Number: 7R43HL055033-02
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1995
Phase I Amount
$100,000
The objective of this application involves the development of a noninvasive measurement of total hemoglobin/hematocrit. The applicant has developed proprietary technology specifically designed for noninvasive chemical analysis by near-infrared photometry. One aspect of this technology is the development of the methods to minimize the impact of radiation scattering by blood and tissue components. It is anticipated that for noninvasive measurement of total hemoglobin/hematocrit, where analyte absorption coefficients are relatively high in comparison with scattering coefficients, the use of specialized, proprietary optical configurations will minimize the effect of scattering and is likely to provide more accurate measurements than previously realized. The applicants will measure and optimize device precision as a function of the optical parameters in these configurations for a device operating on human subjects at wavelengths that should be suitable for a total hemoglobin measurement.National Heart, Lung, and Blood Institute (NHLBI)

Phase II

Contract Number: 2R44HL055033-03
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1997
(last award dollars: 1998)
Phase II Amount
$543,608

The objective of this application involves the development of a noninvasive measurement of total hemoglobin/hematocrit. The applicant has developed proprietary technology specifically designed for noninvasive chemical analysis by near-infrared photometry. One aspect of this technology is the development of the methods to minimize the impact of radiation scattering by blood and tissue components. It is anticipated that for noninvasive measurement of total hemoglobin/ hematocrit, where analyte absorption coefficients are relatively high in comparison with scattering coefficients, the use of specialized, proprietary optical configurations will minimize the effect of scattering and is likely to provide more accurate measurements than previously realized. The applicants propose to measure and optimize device precision as a function of the optical parameters in these configurations for a device operating on human subjects at wavelengths that should be suitable for a total hemoglobin measurement.Thesaurus termsbiomedical equipment development, clinical biomedical equipment, hemoglobin, noninvasive diagnosis, plethysmography, serology /serodiagnosis biotechnology, infrared radiation human subjectNational Heart, Lung and Blood Institute (NHLBI)